← Leaderboards
Michael Benatar
Emory University
$26,653,090
Attributed
$37,406,027
Total exposure
22
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $14.4M · FY2008–25$20M$15M$10M$5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$51,600,299 · 20
FDA$1,814,091 · 2
ATSDR$799,998 · 1
By mechanism
U54$29,342,184 · 15
RF1$11,282,768 · 1
R01$5,612,045 · 4
U01$3,461,876 · 1
U24$2,579,093 · 1
U10$1,936,422 · 1
Top collaborators
- Joanne Wuu7 shared
- Andrea Malaspina5 shared
- Mary-Louise Rogers5 shared
- Merit E Cudkowicz4 shared
- Ralph Lewis Sacco2 shared
- Marc G Weisskopf2 shared
Most similar at Emory University
Same institution · by research overlap
- Allan I Levey$89,469,218
- Monica Willis Parker$2,734,139
- James J Lah$46,199,664
- Fayron Recha Epps$2,394,179
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchTherapeutic DevelopmentBiological MarkersAmyotrophic Lateral SclerosisFundingSuccessCommunitiesNeurodegenerative DisordersClinical TrialsEnrollmentResourcesFutureResearch PersonnelBaseBiologicalMemberRare DiseasesScienceDisease ProgressionPhenotypeMissionTrainingGrantDiagnosis
Grant awards (93)
Pre-Symptomatic Familial ALS (Pre-fALS) Study: From Prodrome and Biomarkers to ALS/FTD Prevention$11,282,768
RF1 · FY2025 · NS · contact PI
Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe)$1,804,011
U54 · FY2025 · NS · contact PI
Clinical Procedures to Support Research in ALS (CAPTURE-ALS)$558,176
U54 · FY2025 · NS · contact PI
Clinical Centers for the NINDS NeuroNEXT(Network of Excellence in Neuroscience Clinical Trials) Consortium$414,261
U24 · FY2025 · NS · contact PI
Administrative Core$298,936
U54 · FY2025 · NS · contact PI
Pilot-Feasibility$88,550
U54 · FY2025 · NS · contact PI
Clinical Centers for the NINDS NeuroNEXT(Network of Excellence in Neuroscience Clinical Trials) Consortium$405,687
U24 · FY2024 · NS · contact PI
Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe)$1,518,603
U54 · FY2023 · NS · contact PI
Multi-Center ALS Biomarker Validation Study (CReATe Biomarkers)$630,895
U01 · FY2023 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Project Core #1$535,840
U54 · FY2023 · NS · contact PI
Clinical Centers for the NINDS NeuroNEXT(Network of Excellence in Neuroscience Clinical Trials) Consortium$422,125
U24 · FY2023 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Administrative Core$315,857
U54 · FY2023 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Pilot Core$69,075
U54 · FY2023 · NS · contact PI
Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe)$1,536,996
U54 · FY2022 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Project Core #1$922,756
U54 · FY2022 · NS · contact PI
Multi-Center ALS Biomarker Validation Study (CReATe Biomarkers)$604,771
U01 · FY2022 · NS · contact PI
Pre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial$549,173
R01 · FY2022 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Administrative Core$310,817
U54 · FY2022 · NS · contact PI
University of Miami NeuroNEXT Trial Site$257,286
U24 · FY2022 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Pilot Core$64,470
U54 · FY2022 · NS · contact PI
Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe)$1,555,588
U54 · FY2021 · NS · contact PI
Multi-Center ALS Biomarker Validation Study (CReATe Biomarkers)$700,180
U01 · FY2021 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Project Core #1$569,575
U54 · FY2021 · NS · contact PI
Pre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial$551,711
R01 · FY2021 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Administrative Core$309,256
U54 · FY2021 · NS · contact PI
University of Miami NeuroNEXT Trial Site$261,085
U24 · FY2021 · NS · contact PI
Clinical Research in ALS and related disorders for Therapeutic Development (CReATe)$194,584
U54 · FY2021 · NS · contact PI
Pre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial; Administrative Supplement$171,858
R01 · FY2021 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Pilot Core$156,570
U54 · FY2021 · NS · contact PI
Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe)$1,633,874
U54 · FY2020 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Project Core #1$633,785
U54 · FY2020 · NS · contact PI
Pre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial$552,712
R01 · FY2020 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Administrative Core$314,475
U54 · FY2020 · NS · contact PI
University of Miami NeuroNEXT Trial Site$264,803
U24 · FY2020 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Pilot Core$64,470
U54 · FY2020 · NS · contact PI
Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe)$1,725,519
U54 · FY2019 · NS · contact PI
Multi-Center ALS Biomarker Validation Study (CReATe Biomarkers)$729,722
U01 · FY2019 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Project Core #1$668,295
U54 · FY2019 · NS · contact PI
Pre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial$559,758
R01 · FY2019 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Administrative Core$337,520
U54 · FY2019 · NS · contact PI
University of Miami NeuroNEXT Trial Site$271,649
U24 · FY2019 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Pilot Core$73,680
U54 · FY2019 · NS · contact PI
Clinical Research in ALS & related disorders for Therapeutic Development (CREATE)$1,238,576
U54 · FY2018 · NS · contact PI
Multi-Center ALS Biomarker Validation Study (CReATe Biomarkers)$796,308
U01 · FY2018 · NS · contact PI
Pre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial$612,744
R01 · FY2018 · NS · contact PI
Project 2$538,168
U54 · FY2018 · NS · contact PI
Project 1$292,650
U54 · FY2018 · NS · contact PI
University of Miami NeuroNEXT Trial Site$282,197
U24 · FY2018 · NS · contact PI
Admin Unit$260,362
U54 · FY2018 · NS · contact PI
Training Component$74,021
U54 · FY2018 · NS · contact PI
Pilot Demonstration$73,375
U54 · FY2018 · NS · contact PI
Clinical Research in ALS & related disorders for Therapeutic Development (CREATE)$1,252,817
U54 · FY2017 · NS · contact PI
Project 2$588,866
U54 · FY2017 · NS · contact PI
Environmental risk factors and gene-environment interactions in ALS risk and progression$399,999
R01 · FY2017 · TS · contact PI
University of Miami: Network of Excellence inNeuroscience Clinical Trials (NEXT)$305,394
U10 · FY2017 · NS · contact PI
Clinical Research in ALS & related disorders for Therapeutic Development (CREATE)$299,785
U54 · FY2017 · NS · contact PI
Clinical Research in ALS & related disorders for Therapeutic Development (CREATE)$297,681
U54 · FY2017 · NS · contact PI
Admin Unit$260,363
U54 · FY2017 · NS · contact PI
Project 1$247,445
U54 · FY2017 · NS · contact PI
Training Component$82,768
U54 · FY2017 · NS · contact PI
Pilot Demonstration$73,375
U54 · FY2017 · NS · contact PI
Clinical Research in ALS & related disorders for Therapeutic Development (CREATE)$1,253,670
U54 · FY2016 · NS · contact PI
Project 2$547,135
U54 · FY2016 · NS · contact PI
Environmental risk factors and gene-environment interactions in ALS risk and progression$399,999
R01 · FY2016 · TS · contact PI
University of Miami: Network of Excellence inNeuroscience Clinical Trials (NEXT)$305,394
U10 · FY2016 · NS · contact PI
Admin Unit$260,363
U54 · FY2016 · NS · contact PI
Project 1$233,124
U54 · FY2016 · NS · contact PI
Training Component$139,673
U54 · FY2016 · NS · contact PI
Pilot Demonstration$73,375
U54 · FY2016 · NS · contact PI
Clinical Research in ALS & related disorders for Therapeutic Development (CREATE)$1,261,491
U54 · FY2015 · NS · contact PI
Project 2$554,965
U54 · FY2015 · NS · contact PI
Admin Unit$263,245
U54 · FY2015 · NS · contact PI
University of Miami: Network of Excellence inNeuroscience Clinical Trials (NEXT)$259,694
U10 · FY2015 · NS · contact PI
Project 1$232,277
U54 · FY2015 · NS · contact PI
Training Component$139,673
U54 · FY2015 · NS · contact PI
Pilot Demonstration$71,331
U54 · FY2015 · NS · contact PI
Clinical Research in ALS & related disorders for Therapeutic Development (CREATE)$1,235,166
U54 · FY2014 · NS · contact PI
Project 2$468,782
U54 · FY2014 · NS · contact PI
Project 1$325,372
U54 · FY2014 · NS · contact PI
Admin Unit$281,350
U54 · FY2014 · NS · contact PI
University of Miami: Network of Excellence inNeuroscience Clinical Trials (NEXT)$256,846
U10 · FY2014 · NS · contact PI
The Effectiveness of Prednisone for the Treatment of Ocular Myasthenia (EPITOME)$116,733
R01 · FY2014 · FD · contact PI
Training Component$96,607
U54 · FY2014 · NS · contact PI
Pilot Demonstration$63,055
U54 · FY2014 · NS · contact PI
Phase II/III Study of Arimoclomol in the Treatment of SOD1 Positive Familial?.$399,424
R01 · FY2013 · FD · contact PI
University of Miami: Network of Excellence inNeuroscience Clinical Trials (NEXT)$198,570
U10 · FY2013 · NS · contact PI
University of Miami: Network of Excellence inNeuroscience Clinical Trials (NEXT)$304,625
U10 · FY2012 · NS · contact PI
The Effectiveness of Prednisone for the Treatment of Ocular Myasthenia (EPITOME)$100,000
R01 · FY2012 · FD · contact PI
Phase II/III Study of Arimoclomol in the Treatment of SOD1 Positive Familial?.$399,489
R01 · FY2011 · FD · contact PI
University of Miami: Network of Excellence inNeuroscience Clinical Trials (NEXT)$305,899
U10 · FY2011 · NS · contact PI
The Effectiveness of Prednisone for the Treatment of Ocular Myasthenia (EPITOME)$398,564
R01 · FY2010 · FD · contact PI
Phase II/III Study of Arimoclomol in the Treatment of SOD1 Positive Familial?.$347,273
R01 · FY2008 · FD · contact PI
Phase II/III Study of Arimoclomol in the Treatment of SOD1 Positive Familial?.$52,608
R01 · FY2008 · FD · contact PI